Testicular cancer is a malignant tumor that develops in the testicles (testicles). Typically, this disease affects young men aged 15 to 40 years. Cancer can manifest itself with various symptoms, such as:
Seminoma is one of the most common types of the disease. Most often found in young men, it is especially sensitive to radiation and chemotherapy. With timely detection and well-chosen treatment, seminoma has a good prognosis.
2.Nonseminoma is a more diverse group of cancers, including several subtypes (embryonic carcinoma, teratoma, choriocarcinoma, and others). Nonseminoma tumors may be more aggressive. A more intensive treatment is usually required, like surgery and/or chemotherapy.
Diagnosis of a testicular tumor usually includes the following steps:
A physical examination, during which the doctor examines the scrotum, testicles, and surrounding area. This allows you to identify the presence of enlarged, hardened or painful areas.
Instrumental techniques, namely ultrasound of the scrotum, which helps to visualize the area with oncology.
CT and MRI can determine the stage and location of a cancerous tumor, as well as assess the condition of the lymph nodes and other organs.
Laboratory studies, including determination of the level of markers of the tumor process in the blood. Namely: alpha-fetoprotein (AFP), beta-chorionic gonadotropin (β-hCG). An increased level of these indicators indicates the presence of testicular cancer.
If a testicular malignancy is suspected, the doctor will refer the patient for a biopsy, which allows for differential diagnosis and confirmation of the diagnosis.
To get a consultation
Testicular cancer treatment methods
Oncology therapy usually includes: surgical removal of tissue affected by the tumor (orchiectomy); chemotherapy; radiation therapy. The set of procedures is selected by the attending physician depending on the stage and spread of the cancer. Early detection and treatment of testicular cancer usually offers a good chance of recovery.
Today, to achieve a positive result, oncologists use a combination of methods to combat the disease, including the newest ones, such as cytokinogenetic therapy (CGT). The combination of CGT with other types of treatment can achieve a positive result.
Positive out one is achieved in 80% of patient cases when using Cytokinogenetic therapy.
Increases the likelihood of tumour egress ion and reduces incidence of relapse.
Cytokinogenetic therapy helps increase the effectiveness of other adjacent treatments by 20-30%.
Cytokinogenetic method reduces adverse events and toxic effects of treatment.
To get a consultation
Emphasis is on the the Tumour Necrosis Factor (TNF). During treatment with CGT, the concentration of TNF cytokine in the blood is increased, which up regulates the immune response to cancer cells and leads to the programmed self death of tumour cells known as apoptosis.
Thymosin alpha-1 can be used with any treatment method in oncology. The technique not only complements and enhances the results of the main treatment, but also makes it easier to tolerate the types of therapy used.
The combination of cytokinogenetic therapy with other methods of combating the disease increases the effectiveness of the treatment process by 20-30%.
CGT helps reduce the negative side effects of the main treatment method.